Swedbank
RAPP

Swedbank’s Rapport Therapeutics RAPP Stock Holding History

Swedbank’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89M Buy
117,400
+4,200
+4% +$154K ﹤0.01% 587
2026
Q1 		$3.54M Hold
113,200
– – ﹤0.01% 593
2025
Q4 		$3.43M Buy
+113,200
New +$3.13M ﹤0.01% 599

Other funds holding RAPP

EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Swedbank's RAPP Position: Q2 2026 in Review

Swedbank increased its Rapport Therapeutics (RAPP) stake by 3.7% in Q2 2026, buying an estimated $154K and bringing the position to 117,400 shares worth $4.89M. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Swedbank first reported a position in RAPP in Q4 2025 and has held it in 3 quarters since. 8 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Swedbank held 117,400 shares of Rapport Therapeutics worth $4.89M as of Q2 2026.
  • Swedbank bought 4,200 Rapport Therapeutics shares in Q2 2026, an estimated $154K.
  • Rapport Therapeutics made up ﹤0.01% of Swedbank's portfolio in Q2 2026, its #587 holding.
  • Swedbank first reported a position in Rapport Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 8 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.